Openbookopenbook
Equity
FMS
+0.0 · +0.00%
USD · NYSE

Fresenius Medical Care Corporation(FMS) Stock Analysis | Healthcare

USD --+0.00%
Reward61Moderate
Risk43Moderate
75%Data
Thin 5% profit margin · 3.7% dividend yield
Value Trap
Market Cap:12.47Bn
ⓘ
Reward Rating
61
Moderate
Reward Assessment
75% data coverage
Top 50% of stocksView factors
ⓘ
Risk Rating
43
Moderate
Risk Assessment

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on FMS to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for FMS, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $26.01.

What is Fresenius Medical Care Corporation?

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally.

FMS · Verdict

Solid reward · moderate risk

FMS stands out on valuation and cash flow, but watch the profitability signal.

Based on 88% data coverage

FMS · Verdict

What’s working & what to watch

Strengths 3

  • Valuation95/100

    P/E 9.7× · PEG 0.82

  • Cash flow71/100

    9% free-cash-flow margin

  • Growth66/100

    Rev +0.4% CAGR · earnings +13.3%

Watchouts 1

  • Profitability38/100

    5% net margin · 9% ROE

Model-based scoring. For information only — not financial advice.

What is Fresenius Medical Care Corporation?

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 12.47B, and a P/E ratio of 12.1x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (61)

The scoring profile indicates moderate reward potential, with valuation and growth as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Similar stocks to compare

A short list of Medical Care Facilities names that are close enough in size to make side-by-side comparison useful.

EHCLarge Cap / 11.9B market cap
Encompass Health Corp
Compare
DVALarge Cap / 11.1B market cap
DaVita HealthCare Partners Inc
Compare
BDULFLarge Cap / 11.1B market cap
Bangkok Dusit Medical Services Public Company Limited
Compare
Company Information
SectorHealthcare
IndustryMedical Care Facilities
Market Cap12.47B
P/E Ratio12.0773
Dividend Yield3.72%
Beta0.839
Insider Activity
12M windowNo data
No insider activity data available for this ticker.
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.